Home » Topics » Immune, BioWorld Science

Immune, BioWorld Science
RSS

Pharmacokinetic model described for BMS-188667

March 18, 1997

First live oral cholera vaccine approved in Canada

March 13, 1997

Activated immunoglobulins reported by Nippon Zoki

March 12, 1997

Positive preliminary results for rotavirus vaccine

March 7, 1997

SangStat receives European patent for Xenoject drugs

March 5, 1997

WF-10 undergoes further clinical studies for AIDS

March 5, 1997

Novel class of immunosuppressants disclosed by Novartis

March 4, 1997

Optivax phase I results reported at AAAI/AAI/CIS meeting

Feb. 27, 1997

Immunoregulatory protein discovered by Boehringer Mannheim

Feb. 26, 1997

Multinational clinical trial results for Zenapax

Feb. 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...